RYZUMVI™ - Reverse Mydriatic

RYZUMVI™ - Reverse Mydriatic

RYZUMVI™ - Reverse Mydriatic

RYZUMVI™ (Phentolamine Ophthalmic Solution) 0.75% is indicated for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents. The only available FDA-approved treatment for the reversal of pharmacologically-induced mydriasis.

RYZUMVI™ is a sterile, clear, and colorless topical ophthalmic solution and comes in a translucent, low-density polyethylene, single-patient-use vial. 

  • Reverse dilation with just 1-2 drops
  • Only available FDA-approved eye drop to rapidly reverse dilation, generally within 90 minutes
  • Shipped in insulated packaging
  • 6 pouches containing 5 vials each
  • Store refrigerated at 2 C to 8 C
  • Protect from freezing

Brand: Ocuphire Pharma



  This is a insulated to reduce excessive heat item and will ship separately via 2nd Day Service. Additional shipping and handling fees apply. Weekly cut off for insulated to reduce excessive heat shipping is Wednesday at 12:00 PM CST. All orders placed after this time will ship the following Monday. This item is not returnable. Learn more about insulated to reduce excessive heat items.

This product is DSCSA tracked.

  Before an order for diagnostic or pharmaceutical products can be processed AMCON is required to keep on file a copy of the Practitioner's therapeutic license. Practitioners are solely responsible for complying by the laws of their state.  AMCON assumes no liability for practitioner compliance.
We cannot accept returns on pharmaceutical products.

Can only ship within US. This product can only be shipped within the United States.

Related Products